Pfizer Asks for New FDA Regulations, Not Guidance, for Social Media
Pfizer submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find it here).
The world's #1 pharmaceutical company stands alone in calling...
Google Defends Sidewiki Despite the Fact That It Is Worthless as a Social Media...
Google submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find it here).
The search giant devoted about 3 pages to defending...
PatientsLikeMe Reports High Rate of Adverse Event Reporting Among Its Members
PatientsLikeMe (PLM) -- an online community for people with "life-changing conditions" -- submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools...
#fdaSM Survey Results
I worked all weekend to submit to the FDA the results of the Pharma Marketing News/Blog survey of readers about FDA's Regulation of Drug & Device Promotion via the Internet &...
Pfizer’s Bait and Switch Facebook Pfan Strategy
Yesterday afternoon at approximately 3 PM ET, @pfizer_news posted this tweet: "Become a Fan of Pfizers official page on Facebook: http://bit.ly/aGX49f" About an hour later I was sent this DM: 'Hi...
If Drugs Were Like Automobiles
According to an Institute for Safe Medication Practices report (see here) more than 1000 reports of patient deaths were received by FDA for rosiglitazone (AVANDIA) in the first three quarters of...
Will FDA’s SM Guidance Resemble Suggestions Made by Industry Group Back in October?
Yesterday, during a Pharma Marketing Talk live podcast/interview, Cynthia Phillips, who is currently Senior Director of Regulatory Labeling and Promotional Compliance at Millennium Pharmaceuticals, Inc., and spokesperson for an adhoc Social...
Geez, GSK! Find Another Source of “Balanced” Commentary
GSK continues to use its "More Than Medicine" blog to focus on Avandia, one of its medicines receiving a lot of attention recently (see Steve Nissen to GSK (and FDA): "Put...
Steve Nissen to GSK (and FDA): “Put Patients First! It’s Time to Pull Avandia...
Internal FDA reports -- part of a fierce debate within the agency over what to do about GSK's Avandia -- obtained by the New York Times, say that "if every diabetic...
“An Eye on Big Pharma”: I am Feautured in NYIT Magazine Article
I received an MA degree in Communication Arts from the New York Institute of Technology in 1988. The school's PR person somehow got wind of what I was doing and convinced...
